These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 14655659)
1. Antibiotic development pipeline runs dry. New drugs to fight resistant organisms are not being developed, experts say. Nelson R Lancet; 2003 Nov; 362(9397):1726-7. PubMed ID: 14655659 [No Abstract] [Full Text] [Related]
2. The antibiotic pipeline--challenges, costs, and values. Wenzel RP N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041 [No Abstract] [Full Text] [Related]
3. Drug companies snub antibiotics as pipeline threatens to run dry. Clarke T Nature; 2003 Sep; 425(6955):225. PubMed ID: 13679874 [No Abstract] [Full Text] [Related]
9. Singapore infectious diseases comes of age. Allen DM Singapore Med J; 1994 Jun; 35(3):314-5. PubMed ID: 7997913 [No Abstract] [Full Text] [Related]
10. Repairing the broken market for antibiotic innovation. Outterson K; Powers JH; Daniel GW; McClellan MB Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108 [TBL] [Abstract][Full Text] [Related]
11. Pay drug companies $1bn for each new antibiotic, says report. Owen J BMJ; 2016 May; 353():i2863. PubMed ID: 27198868 [No Abstract] [Full Text] [Related]
12. Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections. Singer AC; Kirchhelle C; Roberts AP F1000Res; 2019; 8():238. PubMed ID: 30906539 [TBL] [Abstract][Full Text] [Related]
13. Models for change in clinical microbiology. Van Eldere J Clin Microbiol Infect; 2000 Aug; 6(8):445-8. PubMed ID: 11168176 [No Abstract] [Full Text] [Related]
14. Introduction: antibiotic short-course therapy---where are the limits? Finch RG J Int Med Res; 2000; 28 Suppl 1():1A-2A. PubMed ID: 11092224 [No Abstract] [Full Text] [Related]
15. Commentary: How to encourage more diagnostics for infectious diseases. Powers JH BMJ; 2016 Sep; 354():i4744. PubMed ID: 27604999 [No Abstract] [Full Text] [Related]
16. Merck opts for shake-up to clear drug pipeline. Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975 [No Abstract] [Full Text] [Related]
17. The antibiotic pipeline: reviving research and development and speeding drugs to market. Luepke KH; Mohr JF Expert Rev Anti Infect Ther; 2017 May; 15(5):425-433. PubMed ID: 28306360 [TBL] [Abstract][Full Text] [Related]
18. The antibacterial drugs market. Kresse H; Belsey MJ; Rovini H Nat Rev Drug Discov; 2007 Jan; 6(1):19-20. PubMed ID: 17269159 [No Abstract] [Full Text] [Related]
19. Antibiotics: a shot in the arm. Leeb M Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888 [No Abstract] [Full Text] [Related]
20. What are the economic barriers of antibiotic R&D and how can we overcome them? Renwick M; Mossialos E Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625 [No Abstract] [Full Text] [Related] [Next] [New Search]